ESR1 and glioblastoma: Importantly, although lower ER-α expression was observed in GBM TCGA data compared to healthy tissue, survival analysis showed that high ER-α expression is a poor prognostic factor for the patients, which suggests that ER-α expression levels in GBM may not always be proportional to its oncogenic activity.